SHSE:603102 (China)
Â
Class A
Â¥
35.49
(-1.36%)
Dec 25
Business Description
Weihai Baihe Biology Technological Co Ltd
ISIN : CNE100005RB6
Share Class Description:
SHSE:603102: Class ACompare
Compare
Traded in other countries / regions
603102.China IPO Date
2022-01-25Description
Weihai Baihe Biology Technological Co Ltd is engaged in the research and development, production and sales of nutritional health food.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 569.73 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 71.76 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 9.81 | |||||
| Beneish M-Score | -2.03 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.1 | |||||
| 3-Year EPS without NRI Growth Rate | -2.3 | |||||
| 3-Year FCF Growth Rate | -14.3 | |||||
| 3-Year Book Growth Rate | 25.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 8.85 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8.51 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.01 | |||||
| 9-Day RSI | 40.19 | |||||
| 14-Day RSI | 45.45 | |||||
| 6-1 Month Momentum % | 24.09 | |||||
| 12-1 Month Momentum % | -4.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.2 | |||||
| Quick Ratio | 7.56 | |||||
| Cash Ratio | 6.72 | |||||
| Days Inventory | 77.31 | |||||
| Days Sales Outstanding | 18.84 | |||||
| Days Payable | 60.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.11 | |||||
| Dividend Payout Ratio | 0.3 | |||||
| Forward Dividend Yield % | 2.11 | |||||
| 5-Year Yield-on-Cost % | 2.11 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 2.18 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.42 | |||||
| Operating Margin % | 20.36 | |||||
| Net Margin % | 18.58 | |||||
| FCF Margin % | 9.13 | |||||
| ROE % | 10.19 | |||||
| ROA % | 9.02 | |||||
| ROIC % | 28.68 | |||||
| ROC (Joel Greenblatt) % | 45.88 | |||||
| ROCE % | 11.68 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.33 | |||||
| Forward PE Ratio | 12.45 | |||||
| PE Ratio without NRI | 13.93 | |||||
| Price-to-Owner-Earnings | 27.55 | |||||
| PEG Ratio | 1.5 | |||||
| PS Ratio | 2.66 | |||||
| PB Ratio | 1.45 | |||||
| Price-to-Tangible-Book | 1.47 | |||||
| Price-to-Free-Cash-Flow | 29.1 | |||||
| Price-to-Operating-Cash-Flow | 14.77 | |||||
| EV-to-EBIT | 6.55 | |||||
| EV-to-EBITDA | 6.55 | |||||
| EV-to-Revenue | 1.41 | |||||
| EV-to-FCF | 15.88 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.48 | |||||
| Price-to-Graham-Number | 0.96 | |||||
| Price-to-Net-Current-Asset-Value | 1.99 | |||||
| Price-to-Net-Cash | 2.52 | |||||
| Earnings Yield (Greenblatt) % | 15.27 | |||||
| FCF Yield % | 3.35 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Weihai Baihe Biology Technological Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 845.07 | ||
| EPS (TTM) (Â¥) | 2.45 | ||
| Beta | 0 | ||
| Volatility % | 27.88 | ||
| 14-Day RSI | 45.45 | ||
| 14-Day ATR (Â¥) | 1.337065 | ||
| 20-Day SMA (Â¥) | 37.5705 | ||
| 12-1 Month Momentum % | -4.82 | ||
| 52-Week Range (Â¥) | 28.06 - 40.56 | ||
| Shares Outstanding (Mil) | 64 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Weihai Baihe Biology Technological Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Weihai Baihe Biology Technological Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Weihai Baihe Biology Technological Co Ltd Frequently Asked Questions
What is Weihai Baihe Biology Technological Co Ltd(SHSE:603102)'s stock price today?
The current price of SHSE:603102 is ¥35.49. The 52 week high of SHSE:603102 is ¥40.56 and 52 week low is ¥28.06.
When is next earnings date of Weihai Baihe Biology Technological Co Ltd(SHSE:603102)?
The next earnings date of Weihai Baihe Biology Technological Co Ltd(SHSE:603102) is .
Does Weihai Baihe Biology Technological Co Ltd(SHSE:603102) pay dividends? If so, how much?
The Dividend Yield %  of Weihai Baihe Biology Technological Co Ltd(SHSE:603102) is 2.11% (As of Today), Highest Dividend Payout Ratio of Weihai Baihe Biology Technological Co Ltd(SHSE:603102) was 0.3. The lowest was 0.24. And the median was 0.24. The  Forward Dividend Yield % of Weihai Baihe Biology Technological Co Ltd(SHSE:603102) is 2.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers